Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 ...

People with shorter protective caps at the end of their chromosomes (called telomeres) may be more likely to develop ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a ...

Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe symptoms of long COVID among ...

The finding challenges previous notions of the mechanism of leukocyte arrest. The physiological and biochemical data that the authors present argues for an integrin activation that happens in 0.1 to 0 ...

A new international study reveals that leukocyte count could be a key indicator in determining long-term Covid-19 effects in ...

A new study has shown that the most common non-cancer diagnosis—asymptomatic prostatitis—can be made reliably by determining leukocyte number in a sample of urine collected after prostatic ...

Leukocyte cell-derived chemotaxin 2 (LECT2) is a protein that has garnered attention for its multifaceted roles in various physiological and pathological conditions, particularly in the context of ...

Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...